Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Folia Medica|February 14, 2024
Safety and efficacy of ovarian tissue autotransplantation: A systematic literature reviewEirini Giovannopoulou, Maria-Valeria Karakasi, Maria Kouroupi, et al.
Cancers|November 10, 2020
iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung CancerAlexandra Giatromanolaki, Avgi Tsolou, Eleftheria Daridou, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
The Prognostic Value of Ultrasound Findings in Preoperatively Distinguishing between Uncomplicated and Complicated Types of Pediatric Acute Appendicitis Based on Correlation with Intraoperative and Histopathological FindingsKonstantina Bekiaridou, Katerina Kambouri, Alexandra Giatromanolaki, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Predicting Complicated Appendicitis in Children: Pros and Cons of a New Score Combining Clinical Signs, Laboratory Values, and Ultrasound Images (CLU Score)Konstantina Bekiaridou, Katerina Kambouri, Alexandra Giatromanolaki, et al.
Molecular Biology Reports|February 6, 2019
Angiogenic regeneration defines loco-regional recurrence following pre-operative radio-chemotherapy for rectal cancer: a pilot studyMichael I Koukourakis, Ioannis M Koukourakis, Stella Arelaki, et al.
Immunologic Research|November 5, 2020
Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installationAlexandra Giatromanolaki, Ioannis M Koukourakis, Paschalis Chatzipantelis, et al.
Surgical Infections|November 28, 2025
Actinomycosis of the Sigmoid Colon Mimicking Malignancy and Presented with Bowel ObstructionGeorge Pappas-Gogos, Maria Kouroupi, Helen Bolanaki, et al.
Life Sciences|September 8, 2020
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathwaysAlexandra Giatromanolaki, Maria Kouroupi, Stamatia Pouliliou, et al.
Immunobiology|June 11, 2024
Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapyAlexandra Giatromanolaki, Christos Kavazis, Anastasia G Gkegka, et al.
BJR Case Reports|June 16, 2021
Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapyIoannis M Koukourakis, Axiotis G Giakzidis, Maria Kouroupi, et al.
Pageof 3